AC
HALO icon

AlphaCore Capital’s Halozyme HALO Stock Holding History

AlphaCore Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.7M Buy
41,765
+254
+0.6% +$17.9K 0.06% 219
2025
Q4 		$2.79M Buy
41,511
+377
+0.9% +$25.4K 0.06% 227
2025
Q3 		$3.02M Buy
41,134
+23
+0.1% +$1.53K 0.1% 154
2025
Q2 		$2.14M Buy
41,111
+3,005
+8% +$171K 0.08% 180
2025
Q1 		$2.43M Buy
+38,106
New +$2.21M 0.21% 103

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AlphaCore Capital's HALO Position: Q1 2026 in Review

AlphaCore Capital increased its Halozyme (HALO) stake by 0.61% in Q1 2026, buying an estimated $17.9K and bringing the position to 41,765 shares worth $2.7M. The position accounts for 0.06% of the portfolio, ranked #219.

AlphaCore Capital first reported a position in HALO in Q1 2025 and has held it in 5 quarters since. The position peaked at $3.02M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • AlphaCore Capital held 41,765 shares of Halozyme worth $2.7M as of Q1 2026.
  • AlphaCore Capital bought 254 Halozyme shares in Q1 2026, an estimated $17.9K.
  • Halozyme made up 0.06% of AlphaCore Capital's portfolio in Q1 2026, its #219 holding.
  • AlphaCore Capital first reported a position in Halozyme in Q1 2025 and has held it in 5 quarters since.
  • AlphaCore Capital's Halozyme position peaked at $3.02M in Q3 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on AlphaCore Capital's 13F filing for Q1 2026, filed 15 May 2026.